Ling Huang

1.1k total citations
49 papers, 740 citations indexed

About

Ling Huang is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Ling Huang has authored 49 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pathology and Forensic Medicine and 15 papers in Molecular Biology. Recurrent topics in Ling Huang's work include Lymphoma Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (9 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Ling Huang is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (9 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Ling Huang collaborates with scholars based in China, United States and Taiwan. Ling Huang's co-authors include Xuan Gao, Yonghong Liu, Yi‐Long Wu, Jian Su, Xu‐Chao Zhang, Wenyu Li, Sichu Liu, Xinmiao Jiang, Zhi Hong Chen and Tony Mok and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ling Huang

47 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Huang China 13 229 228 211 134 118 49 740
Hirotsugu Noguchi Japan 15 244 1.1× 193 0.8× 174 0.8× 77 0.6× 69 0.6× 66 750
Shunliang Yang China 16 380 1.7× 106 0.5× 275 1.3× 155 1.2× 44 0.4× 33 1.2k
Gülay Bulut Türkiye 15 535 2.3× 174 0.8× 136 0.6× 78 0.6× 114 1.0× 54 925
Takuro Nishikawa Japan 11 221 1.0× 240 1.1× 77 0.4× 106 0.8× 62 0.5× 60 677
Min Kyoung Kim South Korea 19 284 1.2× 385 1.7× 176 0.8× 51 0.4× 239 2.0× 86 1.1k
Carly C. Barron Canada 15 521 2.3× 273 1.2× 161 0.8× 289 2.2× 133 1.1× 33 1.2k
Toshihiko Komai Japan 15 252 1.1× 297 1.3× 85 0.4× 70 0.5× 52 0.4× 53 1.0k
Qiuping Xie China 17 281 1.2× 150 0.7× 74 0.4× 99 0.7× 39 0.3× 43 876
Haiying Liu China 12 176 0.8× 433 1.9× 137 0.6× 95 0.7× 33 0.3× 26 814

Countries citing papers authored by Ling Huang

Since Specialization
Citations

This map shows the geographic impact of Ling Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Huang more than expected).

Fields of papers citing papers by Ling Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Huang. The network helps show where Ling Huang may publish in the future.

Co-authorship network of co-authors of Ling Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Huang. A scholar is included among the top collaborators of Ling Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Huang. Ling Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chengze, Jia‐Da Li, Ling Huang, et al.. (2025). Octyl succinic anhydride-modified chitosan/oxidized sodium alginate Schiff base hydrogel loaded with terbinafine hydrochloride: pH-responsive, self-repairing, antifungal properties. International Journal of Biological Macromolecules. 301. 140431–140431. 12 indexed citations
2.
He, Xuyu, et al.. (2024). lncRNA H19 facilitates vascular neointima formation by targeting miR-125a-3p/FLT1 axis. Acta Biochimica et Biophysica Sinica. 56(10). 1437–1445. 1 indexed citations
3.
Huang, Ling, Zhangyi Liu, Dan Li, et al.. (2024). The Association between Serum Lipid Profile Levels and Hypertension Grades: A Cross-Sectional Study at a Health Examination Center. High Blood Pressure & Cardiovascular Prevention. 32(1). 87–98. 3 indexed citations
4.
5.
Wang, Ning, Pan Lu, Yan Teng, et al.. (2023). Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy. World Journal of Clinical Oncology. 14(12). 606–619. 5 indexed citations
6.
Huang, Ling, Jun Zhang, Bo Wei, et al.. (2023). Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer metabolism. Cell chemical biology. 30(9). 1076–1089.e11. 16 indexed citations
7.
Huang, Ling, Dina Stroopinsky, Giulia Cheloni, et al.. (2022). Personalized tumor vaccine for pancreatic cancer. Cancer Immunology Immunotherapy. 72(2). 301–313. 11 indexed citations
8.
Chen, Cunte, Ling Huang, Lingling Zhou, et al.. (2021). TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma. Cancer Cell International. 21(1). 490–490. 9 indexed citations
9.
Chen, Cunte, Sichu Liu, Xinmiao Jiang, et al.. (2021). Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma. Experimental Hematology and Oncology. 10(1). 20–20. 29 indexed citations
10.
Bodden, Jannis, Dan Sun, Gabby B. Joseph, et al.. (2020). Identification of non-Hodgkin lymphoma patients at risk for treatment-related vertebral density loss and fractures. Osteoporosis International. 32(2). 281–291. 7 indexed citations
11.
Chen, Feili, Xinmiao Jiang, Sichu Liu, et al.. (2020). <p>Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population</p>. Cancer Management and Research. Volume 12. 3003–3012. 14 indexed citations
12.
Huang, Chengzhi, et al.. (2019). COX-2/C-MET/KRAS status-based prognostic nomogram for colorectal cancer: A multicenter cohort study. Saudi Journal of Gastroenterology. 25(5). 293–293. 2 indexed citations
13.
Chen, Feili, Yanwen Li, Xinmiao Jiang, et al.. (2018). Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population. World Neurosurgery. 123. e15–e24. 10 indexed citations
14.
Cheng, Chun‐Chia, Jungshan Chang, Stanley Ching‐Cheng Huang, et al.. (2017). YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells. PLoS ONE. 12(8). e0182149–e0182149. 27 indexed citations
15.
Chang, Yu‐Cheng, Ling Huang, Wei‐Ting Wang, et al.. (2017). Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms. Medical Oncology. 34(5). 83–83. 29 indexed citations
16.
Huang, Ling, Fen Zhang, Sichu Liu, et al.. (2017). ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population. Annals of Hematology. 97(1). 149–159. 2 indexed citations
17.
Chang, Yu‐Cheng, Ling Huang, Chun‐Chia Cheng, et al.. (2017). Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population. Oncotarget. 8(44). 76204–76213. 11 indexed citations
18.
Huang, Ling, et al.. (2016). Road Traffic Accident and its Characteristics in Kathmandu Valley. SHILAP Revista de lepidopterología. 2 indexed citations
19.
Huang, Ling, Shejuan An, Zhihong Chen, et al.. (2014). MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation. Journal of Thoracic Oncology. 9(5). 725–728. 29 indexed citations
20.
Zhang, Wei, Xiaowei Chen, Ling Huang, et al.. (2014). Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis. Experimental and Therapeutic Medicine. 7(5). 1342–1348. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotsugu Noguchi Breakdown of academic impact, for papers by Shunliang Yang Breakdown of academic impact, for papers by Gülay Bulut Breakdown of academic impact, for papers by Takuro Nishikawa Breakdown of academic impact, for papers by Min Kyoung Kim Breakdown of academic impact, for papers by Carly C. Barron Breakdown of academic impact, for papers by Toshihiko Komai Breakdown of academic impact, for papers by Qiuping Xie Breakdown of academic impact, for papers by Haiying Liu
Rankless by CCL
2026